BioInvent International AB (publ) (BINV.ST)

SEK 26.9

(2.87%)

Long Term Debt Summary of BioInvent International AB (publ)

  • BioInvent International AB (publ)'s latest annual long term debt in 2023 was 14.53 Million SEK , down -22.57% from previous year.
  • BioInvent International AB (publ)'s latest quarterly long term debt in 2024 Q2 was 10.4 Million SEK , down 0.0% from previous quarter.
  • BioInvent International AB (publ) reported annual long term debt of 18.77 Million SEK in 2022, down -12.81% from previous year.
  • BioInvent International AB (publ) reported annual long term debt of 21.53 Million SEK in 2021, up 282.32% from previous year.
  • BioInvent International AB (publ) reported quarterly long term debt of 12.47 Million SEK for 2024 Q1, down 0.0% from previous quarter.
  • BioInvent International AB (publ) reported quarterly long term debt of - SEK for 2024 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of BioInvent International AB (publ) (2023 - 2002)

Historical Annual Long Term Debt of BioInvent International AB (publ) (2023 - 2002)

Year Long Term Debt Long Term Debt Growth
2023 14.53 Million SEK -22.57%
2022 18.77 Million SEK -12.81%
2021 21.53 Million SEK 282.32%
2020 5.63 Million SEK -40.54%
2019 9.47 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%
2007 - SEK 0.0%
2006 - SEK 0.0%
2005 - SEK 0.0%
2004 - SEK 0.0%
2003 - SEK 0.0%
2002 - SEK 0.0%

Peer Long Term Debt Comparison of BioInvent International AB (publ)

Name Long Term Debt Long Term Debt Difference
NextCell Pharma AB - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK -238.338%
Abliva AB (publ) 424 Thousand SEK -3328.066%
Active Biotech AB (publ) 3 Million SEK -384.5%
Aptahem AB (publ) - SEK -Infinity%
Alligator Bioscience AB (publ) 7.51 Million SEK -93.387%
BioArctic AB (publ) 2.15 Million SEK -575.418%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 98.453%
Cantargia AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 85.943%
Fluicell AB (publ) - SEK -Infinity%
Genovis AB (publ.) 74.8 Million SEK 80.57%
Hansa Biopharma AB (publ) 844.9 Million SEK 98.28%
Mendus AB (publ) 850 Thousand SEK -1610.0%
Karolinska Development AB (publ) - SEK -Infinity%
LIDDS AB (publ) - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 77.72%
Spago Nanomedical AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 40.7%
Intervacc AB (publ) 142 Thousand SEK -10135.915%
Kancera AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -725.383%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -10587.5%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 87.125%
AcouSort AB (publ) - SEK -Infinity%
Diamyd Medical AB (publ) 30.67 Million SEK 52.612%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -912.187%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 55.389%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 54.503%
Simris Alg AB (publ) 90.74 Million SEK 83.982%
Ziccum AB (publ) 286 Thousand SEK -4982.168%
SynAct Pharma AB 58 Thousand SEK -24960.345%
OncoZenge AB (publ) - SEK -Infinity%
Camurus AB (publ) 13.61 Million SEK -6.773%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -1353.5%
Isofol Medical AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -1610.0%
I-Tech AB - SEK -Infinity%
Cyxone AB (publ) 74 Thousand SEK -19541.892%
Biosergen AB - SEK -Infinity%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Alzinova AB (publ) 800 Thousand SEK -1716.875%
Oncopeptides AB (publ) 106.48 Million SEK 86.35%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Pila Pharma AB (publ) - SEK -Infinity%
Ascelia Pharma AB (publ) 176 Thousand SEK -8158.523%
Diagonal Bio AB (publ) - SEK -Infinity%